Advertisement
Australia markets open in 2 hours 30 minutes
  • ALL ORDS

    8,012.20
    -57.90 (-0.72%)
     
  • AUD/USD

    0.6740
    -0.0012 (-0.18%)
     
  • ASX 200

    7,763.20
    -59.10 (-0.76%)
     
  • OIL

    82.22
    -0.94 (-1.13%)
     
  • GOLD

    2,366.40
    -31.30 (-1.31%)
     
  • Bitcoin AUD

    83,712.42
    +138.27 (+0.17%)
     
  • CMC Crypto 200

    1,207.05
    +40.93 (+3.51%)
     

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics, Inc.
Travere Therapeutics, Inc.

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:

BofA Securities Health Care Conference
Wednesday, May 15, 2024, at 8:00 a.m. PT

Jefferies Global Healthcare Conference
Wednesday, June 5, 2024, at 3:00 p.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

ADVERTISEMENT

Contact Info

Media:
888-969-7879                                        
mediarelations@travere.com

Investors:
888-969-7879                                        
IR@travere.com